Hubei Goto Biopharm Co.,Ltd. (SHE:300966)

China flag China · Delayed Price · Currency is CNY
19.52
+0.26 (1.35%)
Jul 17, 2025, 2:45 PM CST
22.15%
Market Cap2.22B
Revenue (ttm)553.58M
Net Income (ttm)-30.06M
Shares Out115.28M
EPS (ttm)-0.27
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,742,016
Average Volume2,411,315
Open18.95
Previous Close19.26
Day's Range18.95 - 19.65
52-Week Range13.04 - 23.46
Beta0.20
RSI67.15
Earnings DateAug 29, 2025

About Hubei Goto Biopharm

Hubei Goto Biopharm Co.,Ltd. engages in the research, development, production, and sale of steroid drug raw materials and intermediates in China and internationally. It offers starting materials, such as androstenedione, bisnordiol, and 9-hydroxyandrostenedione; intermediates, including sex hormone, progesterone, corticosteroid, and other pharmaceutical raw materials. The company was founded in 2006 and is based in Xiangyang, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 817
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300966
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.